Insight that Drives the Boardroom

Stay ahead with data-backed research, governance analysis, and expert commentary for investors, activists, and corporate leaders.

Activism & Governance

Executive Moves Update – October 17, 2025

This week’s transitions include CEO changes at Verizon, LendingTree, and Kemper, plus CFO shifts at Becton Dickinson, Ameren, Ardelyx, and Starboard placing Peter Feld at Bill.

Executive Moves Update – October 10, 2025

Core Natural Resources, Acadia Healthcare, and Campbell’s replace top leaders amid performance struggles, while Diebold Nixdorf, IDEXX, and Dycom strengthen leadership following strong results.

Executive Moves Update – September 19, 2025

Struggling Crown Castle names Christian Hillabrant CEO, Dexcom appoints interim leaders, Canopy Growth installs CFO amid losses, Bank of America strengthens leadership team. See this week’s key executive moves.

SPAC & IPO Analysis

Daily SPAC Update – March 19, 2026

SPAC IPOs Slow as BHAV Acquisition’s IPO Makes it Only 6 for March. Integrated Wellness Extension and Voyager + Veraxa Biotech Deal Approved. Quartzsea Deal Terminated.

Daily SPAC Update – March 18, 2026

DMY Squared’s Quantum Deal Approved. Winvest Acquisition Extension Approved. Pelican Deal Vote Delayed. Alphatime Sets Extension Vote. Cayson Goes to Vote.

Daily SPAC Update – March 17, 2026

Harry You’s DMY Squared Deal Vote with Horizon Quantum Today. Pelican Acquisition Deal Vote. Abra and GNQ Insilico Deals Announced. Merlin DeSPAC.

Daily SPAC Update – March 13, 2026

Pono Capital Four Downsized $120M IPO. Inflection Point IV + Merlin Deal Approved. Haymaker 4 + Concrete Partners Deal Vote Today.

Daily SPAC Update – March 12, 2026

Metals Acquisition II IPOs. Inflection Point IV + Merlin and Voyager + VERAXA Deal Votes. Harry You Talks Up Quantum Deal for DMY.

Daily SPAC Update – March 10, 2026

Plum IV + Controlled Thermal Resources and Calisa + GoodVision AI Deals. TLGY + Stabecoin X Assets Deal Vote. DMY Squared PIPE Updates.

Daily SPAC Update – March 9, 2026

Drugs Made in America CEO Lynn Stockwell Terminated after Improper Withdrawals. DMY Squared Increases PIPE. Plum IV $4.7B Deal with CTR.

Get it In Your Inbox

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.